The knockdown of HPRT1 was performed using two different siRNAs in the triple-negative MDAMB231 breast cancer cell line (Figure 3B and Figure S1A), and we performed differential gene expression analysis of RNA-seq data (Figure 3B). This evidence concerns the gene HPRT1 and breast carcinoma.